News

Fighting the second pandemic: long COVID

Researchers are defining long COVID and exploring the underlying cause and consequences of the disease that is affecting millions of people.


Large study provides scientists with deeper insight into long COVID

University of Arizona Health Sciences researchers contributed to a National Institutes of Health-funded research effort that identified the most common long COVID symptoms with the aim of improving future diagnostics and treatment.


Dr. Henk Granzier Awarded Distinguished Henry and Phyllis Koffler Prize

Dr. Henk Granzier, Professor of Cellular and Molecular Medicine, was awarded the Henry and Phyllis Koffler Prize for Research/Scholarship/Creative Activity. This prize honors individuals who have made major contributions to their field, with an emphasis on originality.


Warfel Lab Discovers New Mechanisms Driving Prostate Cancer Invasion

The Warfel lab has published a paper in the Journal of Cell Biology identifying PIM1 as a critical regulator actin dynamics and hypoxia-induced cell migration that is critical for prostate cancer invasion.


Computational drug discovery could open new doors

New computational approaches to drug development could lower treatment costs and make new discoveries possible.


Health Sciences genome sequencers a leap forward for research

Devices allow Health Sciences and other college collaborators greater scale and cost-effective methods to improve care.


Dr. James Proffitt Awarded 2023 COM-T Teaching Awards

Assistant Professor James Proffitt received two faculty awards from the College of Medicine – Tucson. Dr. Proffitt received the Academy of Medical Education Scholars (AMES) award for Excellence in Basic Science Teaching, as well as an Award Recognizing Professionalism in Basic Science Teaching.


Training Tomorrow's Genetic Counselors

The Department of Cellular and Molecular Medicine and University of Arizona Health Sciences are training some of Arizona's next genetic counselors. Click for more.


CMM Department Ranked #5 in BRIMR 2022 Rankings

The Department of Cellular and Molecular Medicine (CMM) ranked #5 in the Blue Ridge Institute for Medical Research (BRIMR) 2022 rankings of Cell Biology/Anatomy Departments within Schools of Medicine. CMM ranked #17 in the 2021 BRIMR rankings. The Blue Ridge Institute for Medical Research is a nonprofit organization that publishes rankings of institutions, departments, and investigators based on the amount of funding they receive from the National Institutes for Health (NIH) in a given year.


Dr. Donata Vercelli Named AAAS Fellow

Donata Vercelli, MD, Regents Professor in Cellular & Molecular Medicine was named an American Association for the Advancement of Science (AAAS) Fellow. Dr. Vercelli was recognized for her research on asthma and airway diseases and the genetic and environmental mechanisms that control susceptibility to complex lung diseases.


Researchers Determined to Prevent Viruses From Winning

Under the shadow of increasing viral threats, researchers at the Aegis Consortium are working to create a pandemic-free future.


CMM Researchers Give Talks at ASCB Meeting

Dr. Mert Colpan, Researcher/Scientist in the Gregorio Lab, and Dr. John Ryniawec, Postdoctoral Resarch Associate in the Rogers Lab, were invited to speak at the 2022 American Society for Cell Biology Meeting.


Applying A Team Approach to Health Care Education

Interprofessional education modules at the Arizona Simulation Technology and Education Center teach students the importance of teamwork in health care.


Dr. Julie Ledford and Co-PIs Awarded $3.4M Grant for RaeSedo Inc. to Develop New Therapies for Asthma

Dr. Julie Ledford and her co-principle investigators were awarded a Phase 2 Small Business Technology Transfer grant for their startup company RaeSedo, Inc. The project is titled, "Development of SP-A Derived Peptidomimetics for the Treatment of Asthma" and the total award will amount to $3.4 Million over two years. Dr. Scott Boitano (UArizona), Dr. Josef Vagner (UArizona), and Dr. Monica Kraft (Mount Sinai Medicine) are the co-principle investigators on the project. Click for more about their company, RaeSedo.


Pages